AbCellera Biologics (ABCL) Competitor Comparison
We are evaluating the key criteria listed to compare AbCellera Biologics (ABCL) against its competitors in the Biotechnology industry.
Market Capitalization
98 / 368Gross Profits
21 / 278Total Revenue
120 / 300EBITDA
271 / 337Free Cashflow
242 / 352Quick Ratio
121 / 357Earnings per Share
91 / 359Dividend yield
0 / 6Total Cash
36 / 358Performance 3 years
251 / 368Performance 5 years
326 / 368Performance 10 years
292 / 368Linearity 3 years
172 / 368Linearity 5 years
281 / 368Linearity 10 years
278 / 368Total Rank
255 / 368Dividend Rank
322 / 368Valuation Rank
42 / 368Piotroski Rank
69 / 368Muliplier Rank
247 / 368EBITDA - ABCL ranking 271 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.